Clinical Trials Browser

Recruiting × ripretinib × Clear all

NCT05957367 2026-03-06

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Phase 1/2 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06507683 2024-07-18

Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST

Phase NA Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors